Integrated Nutraceutical Formulation for Comprehensive PCOS Symptom Coverage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for Polycystic Ovary Syndrome (PCOS) are largely symptomatic and lack a comprehensive solution, with existing therapies providing limited relief for the diverse symptoms associated with this hormonal disorder.

Innovation Solution

A nutraceutical composition comprising plant-based proteins, inositol isomers, vitamins, minerals, and fiber, formulated to provide a synergistic effect in addressing the metabolic imbalances underlying PCOS, offering a holistic nutritional supplement for daily consumption.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If symptomatic treatments like metformin, inositol, and topical creams are used, then specific PCOS symptoms are relieved, but comprehensive treatment of all symptoms is not achieved

Engineering Contradiction:
Improvesymptomatic reliefVSAvoidcomprehensive treatment coverage
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple individual PCOS treatment components (inositol isomers, folic acid, vitamins, minerals, fiber, and proteins) into a single integrated nutraceutical formulation. This merging approach allows simultaneous address of multiple PCOS symptoms including ovulation restoration, hormonal balance, skin issues, and metabolic parameters, thereby achieving comprehensive treatment coverage while maintaining ease of use through a single daily supplement.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If multiple individual supplements are taken for different PCOS symptoms, then specific conditions are addressed, but treatment complexity increases

Engineering Contradiction:
Improvesymptom managementVSAvoidnumber of supplements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent consolidates multiple separate supplements into one unified formulation containing inositol isomers, folic acid, vitamins, minerals, fiber, and proteins. This single integrated supplement replaces the need for multiple individual supplements, reducing treatment complexity while maintaining comprehensive symptom management through synergistic combinations of ingredients.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nutraceutical formulation is designed with multi-functionality to address diverse PCOS symptoms simultaneously. The formulation serves multiple purposes: restoring ovulation, regulating hormones, managing weight, improving skin conditions, and supporting metabolic health, all through a single daily supplement, thereby eliminating the need for multiple specialized supplements.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If inositol alone is administered, then ovulation improvement is achieved in about 62% of patients, but comprehensive PCOS symptom resolution is not obtained

Engineering Contradiction:
Improveovulation restoration rateVSAvoidsymptom coverage
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent enhances the efficacy of inositol by combining it with complementary ingredients including folic acid, vitamins (A, B1-B12, C, D, E), minerals (calcium, chromium, iron, potassium, magnesium, manganese, sodium, zinc), fiber, and proteins. This combination synergistically improves ovulation restoration rates while simultaneously addressing other PCOS symptoms such as hormonal imbalance, weight management, skin conditions, and metabolic parameters, thereby achieving comprehensive symptom coverage.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a composite nutraceutical formulation that integrates multiple bioactive components working together. The composite nature of the formulation allows for enhanced biological activity and broader therapeutic effects compared to inositol alone, achieving both high ovulation restoration rates and comprehensive PCOS symptom resolution through the synergistic interaction of multiple ingredients.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20250281516A1Nutraceutical formulation for polycystic ovary syndrome
Publication Date: 2025.09.11 PATODIA RAMESH

AI summary

Nutraceutical food supplement for treatment of young women in post-puberty age suffering from polycystic ovary syndrome with symptoms like irregular menstruation cycles, insulin resistant diabetes, infertility, hair loss, acne and weight gain is provided. Formulations having myo-inositol and its D-chiro isomer along with plant proteins, a carbohydrate (inulin) and other plant fibres; along with well-defined proportions of vitamins (A, B1 to 6; B12 and C); several minerals like Ca, Cr, Fe, K, Mg, Mn, Na and Zn and essential amino acids like L-Glutamine, L-Lysine, and L-Taurine are provided.